Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)
Clinical trial NCT03798054 · COMPLETED
Trial details
- NCT number
- NCT03798054
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-15
- Primary completion
- 2021-03-01
- Enrollment
- 878
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.